Geneva / Hyderabad / Novosibirsk / Baltimore / New York / Atlanta / Ankara / London / New York City / /
Company
Collaborating Laboratories / Bavarian Nordic Company / WHO Collaborating Laboratories / Health / Acambis / 2 WHO Collaborating Smallpox Laboratories / Mary Ann Liebert Inc. / /
Continent
Europe / /
Country
Japan / Russia / United States / Soviet Union / India / /
Currency
USD / / /
Facility
World Trade Center / Lister Institute / Kumamoto Medical Center / Austrian laboratory / /
IndustryTerm
treatment of smallpox / energy / antiviral product / /
National Hospital Organization / New York City Board of Health / World Health Organization / WHO Committee / Committee for Medicinal Products for Human Use / WHO Committee on Orthopoxvirus Infections / Kumamoto / UPMC Center for Health Security / UPMC Center for Health Security / Baltimore / Maryland / and Coeditor-inChief / State Research Center for Virology / Global Commission for the Certification of Smallpox Eradication / 67th World Health Assembly / European Medicines Agency / WHO Advisory Committee on Variola Virus Research / World Health Assembly / European Union / WHO Committee on Vaccines / Lister Institute / WHO Committee on Orthopoxviruses / Advisory Committee / Kumamoto Medical Center / US Centers for Disease Control and Prevention / /
Person
Isao Arita / A. Henderson / /
Position
skilled microbiologist / Director Emeritus / Director General / /
ProvinceOrState
Maryland / Georgia / /
RadioStation
2 WHO / /
Region
former Soviet Union / /
Technology
diagnostic tests / approved research protocols / /
Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science Volume 12, Number 3, 2014 ª Mary Ann Liebert, Inc. DOI: [removed]bsp[removed]comm Commentary